Antioxidants in Kidney Diseases: The Impact of Bardoxolone Methyl

被引：40

作者：

Rojas-Rivera, Jorge ^{[1
]}

Ortiz, Alberto ^{[1
]}

Egido, Jesus ^{[1
]}

机构：

[1] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Div Nephrol & Hypertens, Lab Renal & Vasc Pathol, E-28040 Madrid, Spain

来源：

INTERNATIONAL JOURNAL OF NEPHROLOGY | 2012年 / 2012卷

关键词：

D O I：

10.1155/2012/321714

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Drugs targeting the renin-angiotensin-aldosterone system (RAAS) are the mainstay of therapy to retard the progression of proteinuric chronic kidney disease (CKD) such as diabetic nephropathy. However, diabetic nephropathy is still the first cause of end-stage renal disease. New drugs targeted to the pathogenesis and mechanisms of progression of these diseases beyond RAAS inhibition are needed. There is solid experimental evidence of a key role of oxidative stress and its interrelation with inflammation on renal damage. However, randomized and well-powered trials on these agents in CKD are scarce. We now review the biological bases of oxidative stress and its role in kidney diseases, with focus on diabetic nephropathy, as well as the role of the Keap1-Nrf2 pathway and recent clinical trials targeting this pathway with bardoxolone methyl.

引用

页数：11

共 107 条

[71] Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2 [J].

Prunotto, Marco ;

Carnevali, Maria Luisa ;

Candiano, Giovanni ;

Murtas, Corrado ;

Bruschi, Maurizio ;

Corradini, Emilia ;

Trivelli, Antonella ;

Magnasco, Alberto ;

Petretto, Andrea ;

Santucci, Laura ;

Mattei, Silvia ;

Gatti, Rita ;

Scolari, Francesco ;

Kador, Peter ;

Allegri, Landino ;

Ghiggeri, Gian Marco .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (03) :507-519

[72] Effect of Chronic Antioxidant Therapy with Superoxide Dismutase-Mimetic Drug, Tempol, on Progression of Renal Disease in Rats with Renal Mass Reduction [J].

Quiroz, Yasmir ;

Ferrebuz, Atilio ;

Vaziri, Nosratola D. ;

Rodriguez-Iturbe, Bernardo .

NEPHRON EXPERIMENTAL NEPHROLOGY, 2009, 112 (01) :E31-E42

[73]

Remuzzi G., 1996, LANCET, V349, P1857

[74] Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors [J].

Roberts, CK ;

Won, D ;

Pruthi, S ;

Kurtovic, S ;

Sindhu, RK ;

Vaziri, ND ;

Barnard, RJ .

JOURNAL OF APPLIED PHYSIOLOGY, 2006, 100 (05) :1657-1665

[75] Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension:: all for one and one for all [J].

Rodríguez-Iturbe, B ;

Vaziri, ND ;

Herrera-Acosta, J ;

Johnson, RJ .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 286 (04) :F606-F616

[76]

Rodriguez-Iturbe B, 2002, KIDNEY INT, V62, P1379, DOI 10.1046/j.1523-1755.2002.00561.x

[77] Evidence for peroxynitrite formation in the vasculature of women with preeclampsia [J].

Roggensack, AM ;

Zhang, YL ;

Davidge, ST .

HYPERTENSION, 1999, 33 (01) :83-89

[78] Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade [J].

Ruggenenti, P ;

Mosconi, L ;

Sangalli, F ;

Casiraghi, F ;

Gambara, V ;

Remuzzi, G ;

Remuzzi, A .

KIDNEY INTERNATIONAL, 1999, 55 (03) :984-994

[79] The RAAS in the pathogenesis and treatment of diabetic nephropathy [J].

Ruggenenti, Piero ;

Cravedi, Paolo ;

Remuzzi, Giuseppe .

NATURE REVIEWS NEPHROLOGY, 2010, 6 (06) :319-330

[80] Angiotensin II and reactive oxygen species [J].

Ruiz-Ortega, M ;

Ortiz, A .

ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (9-10) :1258-1260

← 2 3 4 5 6 7 8 9 10 11 →